"For Lyme Disease Sufferers, Could AI Listen When Doctors Won't?" - Emma Court
Lyme disease is a bacterial infection transmitted by a tick and treated with antibiotics. More than 300,000 cases of Lyme are diagnosed annually, according to an estimate by the Centers for Disease Control and Prevention. Lyme has also been on the rise over the years, in large part because climate change, with rising temperatures makes more habitable environments for ticks. Lyme is an enigmatic disease because the perception that it is easy to treat doesn’t always align with patient experiences, said Joel Dudley, PhD, director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai, who is part of the research consortium. “Patients are very vocal that something is going on, and doctors have seen enough patients to know something probably is going on beyond the infection, but nobody knows what it is.” These kinds of advanced, precise tools have already been used in other diseases, like cancer, but not in Lyme because of a lack of funding, Dr. Dudley said.
— Joel Dudley, PhD, Director, Institute for Next Generation Healthcare, Associate Professor, Genetics and Genomic Sciences, Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Executive Vice President, Precision Health, Mount Sinai Health System
"How DNA Tests Can Help Physicians Detect Infectious Diseases Faster"-Megan Knowles
Oct 24, 2018 View All Press Releases"Even More Evidence Finds Link Between Herpes Virus And Alzheimer’s" -Fiza Pirani
Oct 23, 2018 View All Press ReleasesMount Sinai Launches Center for Biomedical Blockchain Research
Jul 24, 2018 View All Press Releases